Related Experiment Video
Updated: Apr 11, 2026
06:51
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
13.5K
Clostridium difficile infection in the twenty-first century
1Aaron Diamond AIDS Research Center , New York, NY 10016, USA.
Emerging Microbes & Infections
|June 4, 2015
Summary
Clostridium difficile infections are a growing epidemic, particularly due to a hypervirulent strain. New treatments and prevention strategies are urgently needed to combat this serious bacterial infection.
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Clostridium difficile is a gram-positive bacterium causing antibiotic-associated diarrhea and colitis.
- A hypervirulent strain (BI/NAP1/027) has altered the infection's epidemiology.
- C. difficile infection (CDI) is now a significant cause of mortality, affecting even low-risk individuals.
Purpose of the Study:
- To review the evolving landscape of Clostridium difficile infection.
- To highlight the urgent need for novel treatment and prevention strategies.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on CDI epidemiology and clinical impact.
Main Results:
- CDI has transitioned from an easily treatable infection to a widespread epidemic.
- The emergence of the BI/NAP1/027 strain has increased disease severity and mortality.
- Current treatment approaches may be insufficient against evolving C. difficile strains.
Conclusions:
- The changing epidemiology of C. difficile infection necessitates a re-evaluation of management strategies.
- Novel therapeutic and preventative measures are critical to control the growing epidemic.
- Further research into C. difficile virulence and host-pathogen interactions is essential.
Related Concept Videos
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
6.7K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.7K
01:22Healthcare Associated Infections II: Preventive Measures
5.0K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K
01:25Clinical Significance of Antibiotic Resistance
52
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
52
01:18Bacterial Gastroenteritis
56
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
56
01:17Chronic Bowel Disorders: Introduction
948
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
948
01:12Bacterial Toxins
78
Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...
78